India · Delayed Price · Currency is INR Indrayani Biotech Statistics
Total Valuation
BOM:526445 has a market cap or net worth of INR 619.29 million. The enterprise value is 2.01 billion.
| Market Cap | 619.29M |
| Enterprise Value | 2.01B |
Important Dates
The next estimated earnings date is Saturday, February 14, 2026.
| Earnings Date | Feb 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:526445 has 45.54 million shares outstanding. The number of shares has increased by 14.56% in one year.
| Current Share Class | 45.54M |
| Shares Outstanding | 45.54M |
| Shares Change (YoY) | +14.56% |
| Shares Change (QoQ) | -17.40% |
| Owned by Insiders (%) | 58.21% |
| Owned by Institutions (%) | 3.66% |
| Float | 18.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.47 |
| PB Ratio | 0.60 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -78.72 |
| EV / Sales | 1.51 |
| EV / EBITDA | 23.64 |
| EV / EBIT | 41.18 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.64, with a Debt / Equity ratio of 1.41.
| Current Ratio | 2.64 |
| Quick Ratio | 1.00 |
| Debt / Equity | 1.41 |
| Debt / EBITDA | 17.18 |
| Debt / FCF | n/a |
| Interest Coverage | 0.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 2.38% |
| Revenue Per Employee | 1.42M |
| Profits Per Employee | -27,297 |
| Employee Count | 936 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:526445 has paid 4.89 million in taxes.
| Income Tax | 4.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.72% in the last 52 weeks. The beta is -0.82, so BOM:526445's price volatility has been lower than the market average.
| Beta (5Y) | -0.82 |
| 52-Week Price Change | -62.72% |
| 50-Day Moving Average | 14.19 |
| 200-Day Moving Average | 15.31 |
| Relative Strength Index (RSI) | 42.40 |
| Average Volume (20 Days) | 32,587 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:526445 had revenue of INR 1.33 billion and -25.55 million in losses.
| Revenue | 1.33B |
| Gross Profit | 381.30M |
| Operating Income | 48.84M |
| Pretax Income | -66.17M |
| Net Income | -25.55M |
| EBITDA | 85.08M |
| EBIT | 48.84M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 69.77 million in cash and 1.46 billion in debt, giving a net cash position of -1.39 billion or -30.57 per share.
| Cash & Cash Equivalents | 69.77M |
| Total Debt | 1.46B |
| Net Cash | -1.39B |
| Net Cash Per Share | -30.57 |
| Equity (Book Value) | 1.04B |
| Book Value Per Share | n/a |
| Working Capital | 1.14B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 28.68%, with operating and profit margins of 3.67% and -1.92%.
| Gross Margin | 28.68% |
| Operating Margin | 3.67% |
| Pretax Margin | -4.98% |
| Profit Margin | -1.92% |
| EBITDA Margin | 6.40% |
| EBIT Margin | 3.67% |
| FCF Margin | n/a |
Dividends & Yields
BOM:526445 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.56% |
| Shareholder Yield | -14.56% |
| Earnings Yield | -4.13% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |